Anavex Life Sciences Corp (AVXL)

[Citrati]

BS on your #.
From the Congressional Budget Office.
"Developing new drugs is a costly and uncertain process, and many potential drugs never make it to market. Only about 12 percent of drugs entering clinical trials are ultimately approved for introduction by the FDA."
Other entities put the success rate between 11 and 16%. No one has it less than 10%.

Average time from P1 to approval 10.5 years. So obviously a long process. Estimated cost $1-2billion. These are all verifiable.

Your 1 in a 100 is a bogus misrepresentation.